Hikma’s profit jumps as demand for generic medicines booms February 26, 2025 Hikma Pharmaceuticals reported a strong financial performance for 2024, with revenue rising nine per cent to $3.13bn (£2.47bn) and operating profit up 67 per cent to $612m (£483m). Profit attributable to shareholders nearly doubled, reaching $359m (£284m), while earnings per share rose 88 per cent. The multinational pharmaceutical company that develops, manufactures, and markets a [...]
Government hits NHS target early and opens door to more private investment February 17, 2025 Government hit NHS appointments target seven months early, as the health secretary warns there is a "hell of lot more to do"
Vitality to offer discounted weight loss drugs in UK first February 12, 2025 Customers are to be offered discounted weight loss treatments through insurance giant Vitality in a UK first. The group, which is UK’s third-largest health insurer behind Bupa and Axa, is to offer discounts of up to 20 per cent for medications such as Wegovy and Mounjaro to its 1.9 million members. The offer is to [...]
Canary Wharf life science hub appoints contractor to transform Elizabeth Line-linked site January 9, 2025 Construction services organisation Morgan Sindall has been appointed lead contractor for a huge office-to-labs conversion in Canary Wharf. The plans for 17 Columbus Courtyard (17CC), which were approved by Tower Hamlets in 2023, will see the existing building transformed into a new state-of-the-art life science and technology hub. When the building is completed in 2026, [...]
Mydentist looks to India for new recruits as loss widens November 20, 2024 Mydentist has sunk further into the red as it looks to recruit more new hires from overseas after the UK Government relaxed the rules. The business, which is one of the largest dental providers in the UK, has said hiring has been constrained by the limited number of dental school places in this country as [...]
Astrazeneca: FTSE 100 giant shrugs off China worries with profit upgrade November 12, 2024 Pharmaceuticals giant Astrazeneca has reported double-digit sales growth on higher demand and said it remains committed to China despite the detention of a high-ranking staff member there. The FTSE 100 firm told markets this morning that total revenue rose 19 per cent to $39.2bn (£30.6bn) in the first nine months of the year. The London-listed [...]
Think care home fees are high? Just wait for Labour’s Budget to set in November 9, 2024 Care home fees are already alarmingly high, but Labour's Budget is likely to see them climb even higher, writes Lisa Morgan.
The Notebook: Why pharmacies could be key to NHS reform November 6, 2024 Want to reform the NHS? How about using the assets we've already got, writes Charac CEO Santosh Sahu in today's Notebook.
GSK: Zantac settlements hit profit but guidance unchanged October 30, 2024 Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance and said its core outlook remained unchanged. Operating profit fell by 86 per cent, and earnings per share slumped due to a settlement charge of £1.8bn related to the Zantac lawsuits. The lawsuits arose [...]
Does the NHS have a communications crisis? October 23, 2024 The NHS has a backlog crisis a staff vacancy crisis and a mental health crisis. Public satisfaction is at an all-time low, and Lord Darzi’s landmark report of the state of the health found that it was in “serious trouble”. But does it boil down to a comms crisis? Jacob Haddad, CEO and co-founder of [...]
